1-BENZYL-6,7-DIMETHOXY-3,4-DIHYDRO-ISOQUINOLINE
|
- $110 - $503.56
- Product name: 1-BENZYL-6,7-DIMETHOXY-3,4-DIHYDRO-ISOQUINOLINE
- CAS: 4876-00-0
- MF: C18H19NO2
- MW: 281.35
- EINECS:
- MDL Number:MFCD00226710
- Synonyms:Isoquinoline, 3,4-dihydro-6,7-dimethoxy-1-(phenylmethyl)-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 25mg
- 1 unit
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0310153
- Product description1-BENZYL-6,7-DIMETHOXY-3,4-DIHYDRO-ISOQUINOLINE 95.00%
- Packaging5MG
- Price$503.56
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS261793
- Product description1-BENZYL-6,7-DIMETHOXY-3,4-DIHYDRO-ISOQUINOLINE AldrichCPR
- Packaging25mg
- Price$110
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberS261793
- Product description1-BENZYL-6,7-DIMETHOXY-3,4-DIHYDRO-ISOQUINOLINE AldrichCPR
- Packaging1 unit
- Price$113
- Updated2025-07-31
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0310153 | 1-BENZYL-6,7-DIMETHOXY-3,4-DIHYDRO-ISOQUINOLINE 95.00% | 5MG | $503.56 | 2021-12-16 | Buy |
| Sigma-Aldrich | S261793 | 1-BENZYL-6,7-DIMETHOXY-3,4-DIHYDRO-ISOQUINOLINE AldrichCPR | 25mg | $110 | 2024-03-01 | Buy |
| Sigma-Aldrich | S261793 | 1-BENZYL-6,7-DIMETHOXY-3,4-DIHYDRO-ISOQUINOLINE AldrichCPR | 1 unit | $113 | 2025-07-31 | Buy |
Properties
Melting point :80 °C (approx)
Boiling point :426.8±45.0 °C(Predicted)
Density :1.11±0.1 g/cm3(Predicted)
pka :5.79±0.20(Predicted)
Boiling point :426.8±45.0 °C(Predicted)
Density :1.11±0.1 g/cm3(Predicted)
pka :5.79±0.20(Predicted)
Safety Information
| Symbol(GHS): |
![]()
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|





